BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16322793)

  • 1. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
    Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
    J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
    Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
    Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
    Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
    BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1.
    Li LX; MacDonald PE; Ahn DS; Oudit GY; Backx PH; Brubaker PL
    Endocrinology; 2006 Jul; 147(7):3318-25. PubMed ID: 16574789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous fraction of Beta vulgaris ameliorates hyperglycemia in diabetic mice due to enhanced glucose stimulated insulin secretion, mediated by acetylcholine and GLP-1, and elevated glucose uptake via increased membrane bound GLUT4 transporters.
    Ul Kabir A; Samad MB; Ahmed A; Jahan MR; Akhter F; Tasnim J; Hasan SM; Sayfe SS; Hannan JM
    PLoS One; 2015; 10(2):e0116546. PubMed ID: 25647228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
    Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
    Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
    Tudurí E; Beiroa D; Porteiro B; López M; Diéguez C; Nogueiras R
    Diabetes Obes Metab; 2015 Aug; 17(8):789-99. PubMed ID: 25962313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice.
    Gault VA; Bhat VK; Irwin N; Flatt PR
    J Biol Chem; 2013 Dec; 288(49):35581-91. PubMed ID: 24165127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
    Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
    J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-lipoic acid attenuates insulin resistance and improves glucose metabolism in high fat diet-fed mice.
    Yang Y; Li W; Liu Y; Li Y; Gao L; Zhao JJ
    Acta Pharmacol Sin; 2014 Oct; 35(10):1285-92. PubMed ID: 25152027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucosylated chondroitin sulfate from sea cucumber in combination with rosiglitazone improved glucose metabolism in the liver of the insulin-resistant mice.
    Hu S; Chang Y; Wang J; Xue C; Li Z; Wang Y
    Biosci Biotechnol Biochem; 2013; 77(11):2263-8. PubMed ID: 24200792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.
    Knauf C; Cani PD; Ait-Belgnaoui A; Benani A; Dray C; Cabou C; Colom A; Uldry M; Rastrelli S; Sabatier E; Godet N; Waget A; Pénicaud L; Valet P; Burcelin R
    Endocrinology; 2008 Oct; 149(10):4768-77. PubMed ID: 18556349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
    Nakashima K; Shimoda M; Hamamoto S; Tatsumi F; Hirukawa H; Tawaramoto K; Kanda Y; Kaku K
    Mol Cell Endocrinol; 2012 Feb; 349(2):281-8. PubMed ID: 22108438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing.
    Knauf C; Cani PD; Kim DH; Iglesias MA; Chabo C; Waget A; Colom A; Rastrelli S; Delzenne NM; Drucker DJ; Seeley RJ; Burcelin R
    Diabetes; 2008 Oct; 57(10):2603-12. PubMed ID: 18519802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.
    Cani PD; Knauf C; Iglesias MA; Drucker DJ; Delzenne NM; Burcelin R
    Diabetes; 2006 May; 55(5):1484-90. PubMed ID: 16644709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia.
    Green CJ; Henriksen TI; Pedersen BK; Solomon TP
    PLoS One; 2012; 7(8):e44284. PubMed ID: 22937169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.